Inventor
JIN HEE KYUNG
KR21 patents
⚠️ This page may combine multiple inventors who share the name “JIN HEE KYUNG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND
14 patentsUS11899025B2Feb 13, 2024
Pharmaceutical composition for preventing or treating neurodegenerative diseases comprising COX2 acetylating agent as active ingredient
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND1 citations73
US12399184B2Aug 26, 2025
Pharmaceutical composition for preventing or treating neurodegenerative diseases comprising COX2 acetylating agent as active ingredient
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations62
US12332244B2Jun 17, 2025
Composition for diagnosing diseases associated with COX2 overexpression and screening method therefor
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations62
US11766444B2Sep 26, 2023
Pharmaceutical composition for preventing or treating degenerative brain disorders including HDL-APOM-S1P as active ingredient
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations62
US12398109B2Aug 26, 2025
2-amino-2-(1,2,3-triazole-4-yl)propane-1,3-diol derivative of novel compound for directly inhibiting ASM activity, and use thereof
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations61
US11466305B2Oct 11, 2022
Amyotrophic lateral sclerosis diagnostic composition using acid sphingomyelinase, and method for detecting diagnostic markers
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations61
US11279744B2Mar 22, 2022
Neuropeptide Y fragment capable of releasing hematopoietic stem cells into blood and treating osteoporosis
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations61
US11007228B2May 18, 2021
Pharmaceutical composition containing stem cell in which vascular endothelial growth factor is overexpressed as effective ingredient for preventing or treating neurodegenerative disease
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations61
US11345671B2May 31, 2022
Phenylsulfonyl oxazole derivative and use thereof
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations59
US12570617B2Mar 10, 2026
Use of triazole compound as ghrelin receptor agonist
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US12545745B2Feb 10, 2026
Method for treating a degenerative neurological disorders comprising administering ASM inhibitor
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US10543254B2Jan 28, 2020
Composition containing neuropeptide Y for inhibiting side effects of anticancer agents
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US10323064B2Jun 18, 2019
Peptides for treating bone diseases and use thereof
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
US10143727B2Dec 4, 2018
Method using an Y1 receptor activator for treating an anticancer agent-induced nephrotoxic injury
KYUNGPOOK NAT UNIV IND ACADEMIC COOP FOUND0 citations51
KYUNGPOOK NATIONAL UNIV INDUSTRY—ACADEMIC COOPERATION FOUNDATION
4 patentsUS12306191B2May 20, 2025
Composition for diagnosis of degenerative neurological diseases
KYUNGPOOK NATIONAL UNIV INDUSTRY—ACADEMIC COOPERATION FOUNDATION0 citations62
US11242529B2Feb 8, 2022
Method for treating a neurological disorder comprising administering ASM inhibitors
KYUNGPOOK NATIONAL UNIV INDUSTRY—ACADEMIC COOPERATION FOUNDATION0 citations61
US10682373B2Jun 16, 2020
Method for treating a degenerative neurological disorders comprising administering ASM inhibitor
KYUNGPOOK NATIONAL UNIV INDUSTRY—ACADEMIC COOPERATION FOUNDATION0 citations51
US10098855B2Oct 16, 2018
Composition comprising ASM inhibitor as active ingredient for preventing or treating degenerative neurological disorders
KYUNGPOOK NATIONAL UNIV INDUSTRY—ACADEMIC COOPERATION FOUNDATION1 citations51
KYUNGPOOK NAT UNIV INDUSTRY-ACADEMIC COOP FOUND
2 patentsUS9724334B1Aug 8, 2017
Method for treating a neurodegenerative disease or depression comprising administering derivatives of 2-amino-2-(1-dodecyl-1H-1,2,3-triazol-4-yl)propane-1,3-diol
KYUNGPOOK NAT UNIV INDUSTRY-ACADEMIC COOP FOUND4 citations72
US9724394B2Aug 8, 2017
Pharmaceutical composition for preventing or treating osteoporosis which comprises neuropeptide Y as active ingredient
KYUNGPOOK NAT UNIV INDUSTRY-ACADEMIC COOP FOUND0 citations49